Redifferentiation Therapy in Brain Tumors: Long-lasting Complete Regression of Glioblastomas and an Anaplastic Astrocytoma Under Long Term 1-alpha-hydroxycholecalciferol
Authors:
- 1 January 2001
- journal article
- case report
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 51 (1) , 57-66
Abstract
Purpose. Classical and new therapies in anaplastic astrocytomas and glioblastomas do not yield sufficient results. Agents able to redifferentiate neoplastic cells in vitroare known. We proposed...Keywords
This publication has 43 references indexed in Scilit:
- Pre-radiation Chemotherapy for Malignant Glioma in AdultsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1996
- Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?Journal of Neurosurgery, 1995
- Differentiation of neoplastic cells toward normal induced by vitamin D3 derivatives.1994
- The New WHO Classification of Brain TumoursBrain Pathology, 1993
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI: Journal of the National Cancer Institute, 1993
- Vitamin D: A modulator of cell proliferation and differentiationThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Grading of astrocytomas: A simple and reproducible methodCancer, 1988
- Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.Journal of Cell Biology, 1984
- Metabolism of 1α-hydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3 in perfused rat liverBiochemical and Biophysical Research Communications, 1975